Home
-
What’s in Store for Pharma in 2026 & Beyond?
Evolving tariff/trade policy, US drug pricing reforms, and a changing global landscape are contributing to an uncertain environment. A DCAT Week education program, featuring experts from IQVIA, will provide in-depth insights on pharma industry performance.
-
Manufacturing Outlook: A Pharma & CDMO View
The wave of US pharmaceutical manufacturing investments has garnered the headlines, but are geographic capacity shifts really in the making? A DCAT Week education program will provide expert analysis, including on the all-important, “make-versus-buy” decision.
-
Blockbuster Contenders: The Class of 2026
What new products, recently or expected to launch in 2026, show blockbuster potential or will be transformative in key therapeutic areas? A look at the companies and products rising to the top of the class.
DCAT MEMBER COMPANY COMMUNITY
-
New DCAT Member Company Alert
Welcome to the newest Member Companies in the Drug, Chemical & Associated Technologies Association (DCAT). DCAT is pleased to welcome the following companies to the DCAT Member Community. To view…
-
ESG Update: DCAT Member Companies in the Community
The latest ESG (environmental, social and governance)news from DCAT Member Companies on how they are making an impact globally and in their local communities. Have a ESG news announcement to share for…
-
People on the Move
Here are the latest moves and promotions of employees from the DCAT Member Company community. To submit a request to be included in People on the Move, click here. From the…
-
New Episode: Production to Prescription Podcast: 2025: The Bio/Pharma Industry’s Year in Review
Without question, evolving US tariff and trade policy was the story of the year in 2025, and how such policy will be implemented looms large. At the same time, the…
